Descrizione del progetto
Guida IA per la chirurgia oculare assistita da robot
Le patologie retiniche sono la principale causa di danno visivo nei paesi industrializzati e una crescente preoccupazione per la salute pubblica. L’esecuzione di interventi chirurgici direttamente sulla retina tramite strumenti microchirurgici ultrasottili e con campo visivo limitato è una sfida che richiede personale chirurgico altamente qualificato ed esperto. Il progetto GEYEDANCE, finanziato dall’UE, introdurrà metodiche di intelligenza artificiale nella robotica chirurgica al fine di fornire un supporto avanzato agli utenti e ridurre il carico mentale e fisico del chirurgo. GEYEDANCE genererà una tecnologia tangibile e «prossima alla certificazione» ed eseguirà una prima sperimentazione clinica. In conclusione, GEYEDANCE aiuterà i medici chirurghi della retina a ottimizzare la loro attività e a contribuire a migliori esiti chirurgici a beneficio dei futuri pazienti.
Obiettivo
"Retina indications are the leading cause of visual impairment in industrialized countries and posing a big unmet socio-economic challenge. Performing surgical actions directly at the retina - one of the most delicate and sensitive areas of the human body - with ultra-thin microsurgical instruments and with a limited view makes retina surgery a very challenging discipline with surgeons working at the limit of what is possible, requiring years of training and experience to reach proficiency.
The GEYEDANCE project is directly addressing this need by translating methods from Artificial Intelligence to the area of surgical robotics, together to be used for an advanced user support for reducing the mental and physical load of the surgeon. Work in the project is building on two existing main blocks - the CE certified robot platform PSS from project partner Preceyes, and a prototype for a Common-Path OCT system with extended measurement depth from partner ACMIT. For the AI-components to be developed, two European leading groups in this domain - ALTAIR/University of Verona and ARTORG/University of Bern - are part of the consortium. Seamless involvement of key stakeholders during the complete development phase is indispensable for a meaningful outcome, and thus a prominent board of world-wide leading eye surgeons, led by partner University of Ferrara, will provide user insight and evaluate the resulting advanced robotic solution. Development and validation of the GEYEDANCE system is strongly supported by industrial partners Carl Zeiss AG and Carl Zeiss Meditec AG.
In-line with the concept of the “Innovation Actions” instrument, the project aims to generate tangible and “close-to-certification"" technology reaching a TRL of 7 (or even higher), being evaluated in the framework of a first clinical trial. All together, the planned AI-based guidance system GEYEDANCE will help the consortium to further consolidate their leading position worldwide, will help retinal surgeons to optimize their task, and finally will help the patient by contributing to a better surgical outcome."
Campo scientifico
- natural sciencescomputer and information sciencesartificial intelligence
- medical and health sciencesclinical medicinesurgery
- medical and health sciencesclinical medicineophthalmology
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringrobotics
Parole chiave
Programma(i)
Argomento(i)
Invito a presentare proposte
HORIZON-CL4-2021-DIGITAL-EMERGING-01
Vedi altri progetti per questo bandoMeccanismo di finanziamento
HORIZON-IA - HORIZON Innovation ActionsCoordinatore
2700 Wiener Neustadt
Austria
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.